Subscribe To
Avalyn Pharma Showcasing Therapeutic Approach and Clinical Status at ATS 2023 and the Respiratory Innovation Summit (RIS)
– Avalyn CEO to Present in Company Showcase and Moderate Panel Discussion at ATS RIS – – Results from Long-Term Treatment of Pulmonary Fibrosis with AP01 to be Presented at ATS – SEATTLE, May 11, 2023 (GLOBE NEWSWIRE) — Avalyn Pharma Inc., a clinical-stage biopharmaceutical company developing inhaled therapies to treat life-threatening pulmonary diseases, today […] The post Avalyn Pharma Showcasing Therapeutic Approach and Clinical Status at ATS 2023 and the Respiratory Innovation Summit (RIS) a...
Read More
Content Topics
Avalyn
Pharma
Showcasing
Therapeutic
Approach
Clinical
Status
Respiratory
Innovation
Summit
Forex
Posted: May 11 2023, 12:00
Author Name: forextv
Views: 102421